Monitoring the Effectiveness of Treatment in Women with Schizophrenia: New Specialized Cooperative Approaches
M Natividad, MV Seeman, JP Paolini, A Balagué… - Brain Sciences, 2023 - mdpi.com
Women with schizophrenia have specific health needs that differ from those of men and that
change through successive life stages. We aimed to review the biopsychosocial literature on …
change through successive life stages. We aimed to review the biopsychosocial literature on …
Efficacy and acceptability of interventions to reduce antipsychotic polypharmacy: A systematic review and meta-analysis of randomized clinical trials
O Köhler-Forsberg, M Højlund, C Rohde… - Schizophrenia …, 2024 - Elsevier
Background Antipsychotic polypharmacy (APP) is frequent but evidence-based guidelines
on reducing APP to antipsychotic monotherapy (APM) are sparse. We aimed to …
on reducing APP to antipsychotic monotherapy (APM) are sparse. We aimed to …
Challenges, unmet needs and future directions–a critical evaluation of the clinical trial landscape in schizophrenia research
Introduction Developing novel antipsychotic mechanisms of action and repurposing
established compounds for the treatment of schizophrenia is of utmost importance to …
established compounds for the treatment of schizophrenia is of utmost importance to …
Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts
A Gillespie, EM Walker, E Hannon, G McQueen… - medRxiv, 2023 - medrxiv.org
The second-generation antipsychotic clozapine is used as a medication for treatment-
resistant schizophrenia. It has previously been associated with epigenetic changes in pre …
resistant schizophrenia. It has previously been associated with epigenetic changes in pre …
[HTML][HTML] Biomarkers of treatment-resistant schizophrenia: A systematic review
Abstract Treatment-resistant schizophrenia (TRS) is associated with great disability,
functional impairment, and substantial socioeconomic costs. While clozapine is indicated in …
functional impairment, and substantial socioeconomic costs. While clozapine is indicated in …
[PDF][PDF] 难治性精神分裂症药物治疗进展
陆铖， 马瑞， 高华， 贾乐川 - Clinical Medication Journal, 2023 - lcywzlzz.com
精神分裂症是临床常见的精神疾病之一, 以思维, 行为, 情感障碍, 精神活动不协调为主要临床
表现, 具有病情迁延, 复发率高, 预后差等特点, 临床多采用药物治疗, 控制患者病情 …
表现, 具有病情迁延, 复发率高, 预后差等特点, 临床多采用药物治疗, 控制患者病情 …